Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 11 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avalo Therapeutics, Inc. | 47,350,000 | reported | 07 Mar 2022 | tx 147+65,869,353−19,340,843 |
| CTD HOLDINGS INC | 15,795,769 | reported | 30 Sept 2020 | tx 16−1,852,545 |
| OBALON THERAPEUTICS INC | 7,223,346 | reported | 28 Jun 2021 | tx 36+7,130,806−9,434,275 |
| EnteroMedics Inc | 5,316,400 | reported | 23 Sept 2020 | tx 52+633,681,082−315,000,000 |
| TENAX THERAPEUTICS, INC. | 4,773,269 | reported | 08 Jul 2021 | tx 2+9,546,538 |
| ADVANCED MAGNETICS INC | 4,120,000 | reported | 27 Jan 2020 | tx 6+90,000 |
| VICAL INC | 2,170,000 | reported | 10 Jan 2019 | tx 27+151,805−2,190,500 |
| PAIN THERAPEUTICS INC | 2,164,000 | reported | 20 Aug 2018 | tx 9−1,256,000 |
| KIORA PHARMACEUTICALS INC | 1,045,963 | reported | 29 Jul 2021 | tx 69+6,947,473−3,157,230 |
| ACHIEVE LIFE SCIENCES, INC. | 1,026,000 | reported | 11 Jun 2019 | tx 30+12,813−264,963 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2022 | PURCHASE | Avalo Therapeutics, Inc. | 135,000 | 0.70 USD | |
| 07 Mar 2022 | PURCHASE | Avalo Therapeutics, Inc. | 325,000 | 0.66 USD | |
| 03 Mar 2022 | PURCHASE | Avalo Therapeutics, Inc. | 50,000 | 0.71 USD | |
| 17 Feb 2022 | PURCHASE | Avalo Therapeutics, Inc. | 150,000 | 0.82 USD | |
| 22 Feb 2022 | PURCHASE | Avalo Therapeutics, Inc. | 83,000 | 0.77 USD | |
| 18 Feb 2022 | PURCHASE | Avalo Therapeutics, Inc. | 55,000 | 0.82 USD | |
| 13 Jan 2022 | PURCHASE | Avalo Therapeutics, Inc. | 312,700 | 1.00 USD | |
| 12 Jan 2022 | PURCHASE | Avalo Therapeutics, Inc. | 57,300 | 1.04 USD | |
| 14 Jan 2022 | PURCHASE | Avalo Therapeutics, Inc. | 85,000 | 0.93 USD | |
| 16 Aug 2021 | PURCHASE | Avalo Therapeutics, Inc. | 30,000 | 2.75 USD | |
| 18 Aug 2021 | PURCHASE | Avalo Therapeutics, Inc. | 20,000 | 2.78 USD | |
| 28 Jul 2021 | SALE | KIORA PHARMACEUTICALS INC | 375,443 | 3.28 USD | |
| 27 Jul 2021 | SALE | KIORA PHARMACEUTICALS INC | 532,069 | 4.59 USD | |
| 29 Jul 2021 | SALE | KIORA PHARMACEUTICALS INC | 400,000 | 3.00 USD | |
| 27 Jul 2021 | SALE | KIORA PHARMACEUTICALS INC | 581,614 | 3.80 USD | |
| 27 Jul 2021 | SALE | KIORA PHARMACEUTICALS INC | 729,114 | 5.44 USD | |
| 27 Jul 2021 | SALE | KIORA PHARMACEUTICALS INC | 461,797 | 6.45 USD | |
| 27 Jul 2021 | SALE | KIORA PHARMACEUTICALS INC | 73,101 | 7.06 USD | |
| 27 Jul 2021 | CONVERSION | KIORA PHARMACEUTICALS INC | 852,500 | 4.80 USD | |
| 27 Jul 2021 | CONVERSION | KIORA PHARMACEUTICALS INC | 4,092 | 0.00 USD | deriv |
| 08 Jul 2021 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 4,773,269 | — | deriv |
| 08 Jul 2021 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 4,773,269 | — | deriv |
| 28 Jun 2021 | EXERCISE | OBALON THERAPEUTICS INC | 1,479,713 | — | |
| 28 Jun 2021 | EXERCISE | OBALON THERAPEUTICS INC | 0 | 0.00 USD | |
| 28 Jun 2021 | EXERCISE | OBALON THERAPEUTICS INC | 676,440 | — |